Shahriar Absar

BRAC University — BD

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index591citations16works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protease and Inhibitor Mechanisms(5), Blood Coagulation and Thrombosis Mechanisms(5), Inhalation and Respiratory Drug Delivery(5), Neonatal Respiratory Health Research(3), Pulmonary Hypertension Research and Treatments(3)

Publications15 total

Deep Neural Network models for diagnosis of COVID-19 Respiratory diseases by analyzing CT-Scans and Explain-ability using trained models
2022 International Conference on Inventive Computation Technologies (ICICT)·2022· 2 cited
Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH
Pharmaceutical Research·2016· 67 citedOpen Access
Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy
Journal of Thrombosis and Haemostasis·2015· 36 citedOpen Access
Newer devices and improved formulations of inhaled insulin
Expert Opinion on Drug Delivery·2014· 18 cited
Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension
Molecular Pharmaceutics·2014· 45 cited
Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature
International Journal of Pharmaceutics·2014· 77 citedOpen Access
Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis
Journal of Controlled Release·2014· 55 cited
Serum albumin–protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules
Journal of Biomedical Materials Research Part A·2013· 8 citedOpen Access
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals
European Journal of Pharmaceutical Sciences·2013· 141 cited
Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy
Pharmaceutical Research·2013· 67 cited
Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: An approach for localized thrombolysis
Thrombosis Research·2012· 19 cited
Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models
American Journal of Physiology-Lung Cellular and Molecular Physiology·2012· 19 cited
CALL FOR PAPERS Bioengineering the Lung: Molecules, Materials, Matrix, Morphology, and Mechanics Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models
2012
Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis
Journal of Controlled Release·2011· 36 cited
Efficacy of nebulized ipratropium bromide versus salbutamol in Infants with actute bronchiolities
Bangladesh Medical Research Council Bulletin·1970· 1 citedOpen Access

Frequent Co-authors

Fakhrul Ahsan(12), Nilesh Gupta(7), Kamrun Nahar(6), Brijeshkumar Patel(5), Kamrun Nahar(5), Young Min Kwon(5), Robert Gauvin(4), Vivek Gupta(3), Sun-A Choi(3), Victor C. Yang(3), Ali Khademhosseini(3), Jahidur Rashid(2), Ali Khademhosseini(1), Fahad Alsaikhan(1), Venkata Ramana Kotamraju(1), Ivan F. McMurtry(1), Masahiko Oka(1), Masanobu Komatsu(1), Eva Nozik‐Grayck(1), Everardo Cobos(1)